| Molecular and clinical significance of fibroblast growth factor 2 (FGF2/bFGF) in malignancies of solid and hematological cancers for personalized therapies MR Akl, P Nagpal, NM Ayoub, B Tai, SA Prabhu, CM Capac, M Gliksman, ... Oncotarget 7 (28), 44735, 2016 | 211 | 2016 |
| Protein calorie malnutrition, nutritional intervention and personalized cancer care A Gangadharan, SE Choi, A Hassan, NM Ayoub, G Durante, S Balwani, ... Oncotarget 8 (14), 24009, 2017 | 154 | 2017 |
| Olive phenolics as c-Met inhibitors:(-)-Oleocanthal attenuates cell proliferation, invasiveness, and tumor growth in breast cancer models MR Akl, NM Ayoub, MM Mohyeldin, BA Busnena, AI Foudah, YY Liu, ... PloS one 9 (5), e97622, 2014 | 141 | 2014 |
| Gold nanoparticles and angiogenesis: molecular mechanisms and biomedical applications RS Darweesh, NM Ayoub, S Nazzal International journal of nanomedicine, 7643-7663, 2019 | 137 | 2019 |
| Immunotherapy for HER2-positive breast cancer: recent advances and combination therapeutic approaches NM Ayoub, KM Al-Shami, RJ Yaghan Breast Cancer: Targets and Therapy, 53-69, 2019 | 121 | 2019 |
| Influence of dietary intake of dairy products on dysmenorrhea KK Abdul‐Razzak, NM Ayoub, AA Abu‐Taleb, BA Obeidat Journal of Obstetrics and Gynaecology Research 36 (2), 377-383, 2010 | 112 | 2010 |
| Molecular and clinical profiles of syndecan-1 in solid and hematological cancer for prognosis and precision medicine MR Akl, P Nagpal, NM Ayoub, SA Prabhu, M Gliksman, B Tai, A Hatipoglu, ... Oncotarget 6 (30), 28693, 2015 | 97 | 2015 |
| Targeting angiogenesis in breast cancer: current evidence and future perspectives of novel anti-angiogenic approaches NM Ayoub, SK Jaradat, KM Al-Shami, AE Alkhalifa Frontiers in pharmacology 13, 838133, 2022 | 93 | 2022 |
| The olive oil phenolic (-)-oleocanthal modulates estrogen receptor expression in luminal breast cancer in vitro and in vivo and synergizes with tamoxifen treatment NM Ayoub, AB Siddique, HY Ebrahim, MM Mohyeldin, KA El Sayed European journal of pharmacology 810, 100-111, 2017 | 77 | 2017 |
| Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents AA Inamdar, A Goy, NM Ayoub, C Attia, L Oton, V Taruvai, M Costales, ... Oncotarget 7 (30), 48692, 2016 | 75 | 2016 |
| Pseurotin A as a novel suppressor of hormone dependent breast cancer progression and recurrence by inhibiting PCSK9 secretion and interaction with LDL receptor KS Abdelwahed, AB Siddique, MM Mohyeldin, MH Qusa, AA Goda, ... Pharmacological research 158, 104847, 2020 | 62 | 2020 |
| Indole diterpene alkaloids as novel inhibitors of the Wnt/β-catenin pathway in breast cancer cells AA Sallam, NM Ayoub, AI Foudah, CR Gissendanner, SA Meyer, ... European journal of medicinal chemistry 70, 594-606, 2013 | 62 | 2013 |
| Sesamin synergistically potentiates the anticancer effects of γ-tocotrienol in mammary cancer cell lines MR Akl, NM Ayoub, BS Abuasal, A Kaddoumi, PW Sylvester Fitoterapia 84, 347-359, 2013 | 60 | 2013 |
| Potential role of tocotrienols in the treatment and prevention of breast cancer PW Sylvester, MR Akl, A Malaviya, P Parajuli, S Ananthula, RV Tiwari, ... Biofactors 40 (1), 49-58, 2014 | 58 | 2014 |
| A proposal of a clinically based classification for idiopathic granulomatous mastitis R Yaghan, S Hamouri, NM Ayoub, L Yaghan, T Mazahreh Asian Pacific journal of cancer prevention: APJCP 20 (3), 929, 2019 | 57 | 2019 |
| Novel combination therapies for the treatment of solid cancers NM Ayoub Frontiers in oncology 11, 708943, 2021 | 55 | 2021 |
| Impact of obesity on Clinicopathologic characteristics and disease prognosis in pre‐and postmenopausal breast cancer patients: a retrospective institutional study NM Ayoub, RJ Yaghan, NM Abdo, II Matalka, LM Akhu-Zaheya, ... Journal of obesity 2019 (1), 3820759, 2019 | 53 | 2019 |
| Pediatric Hodgkin lymphoma–biomarkers, drugs, and clinical trials for translational science and medicine P Nagpal, MR Akl, NM Ayoub, T Tomiyama, T Cousins, B Tai, N Carroll, ... Oncotarget 7 (41), 67551, 2016 | 52 | 2016 |
| Araguspongine C induces autophagic death in breast cancer cells through suppression of c-Met and HER2 receptor tyrosine kinase signaling MR Akl, NM Ayoub, HY Ebrahim, MM Mohyeldin, KY Orabi, AI Foudah, ... Marine drugs 13 (1), 288-311, 2015 | 52 | 2015 |
| γ‐Tocotrienol inhibits HGF‐dependent mitogenesis and Met activation in highly malignant mammary tumour cells NM Ayoub, SV Bachawal, PW Sylvester Cell proliferation 44 (6), 516-526, 2011 | 48 | 2011 |
